Literature DB >> 28604100

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015).

Theodoros Karampatakis1, Charalampos Antachopoulos1, Athanassios Tsakris2, Emmanuel Roilides1.   

Abstract

Carbapenem-resistant Acinetobacter baumannii (CRAB) is endemic in Greece. CRAB initially emerged in 2000 and since then, carbapenemases still have a crucial role in CRAB appearance, except for a few cases resulting from efflux pump or outer-membrane protein mechanisms. OXA-type carbapenemases present the highest prevalence worldwide and bla OXA-23-like and bla OXA-58-like are the most important genes found; VIM-yielding CRAB have also been detected, while a single CRAB isolate producing NDM has quite recently emerged in Greece. The predominant OXA-23 producers are associated with multilocus sequence typing Pasteur scheme sequence type 2 clonal strains of the international clone II. The emergence of colistin-resistant CRAB has complicated the treatment of such infections and the interpretation of susceptibility data. Infection control measures and adjusted antimicrobial treatment strategies could confine CRAB spread. The aim of this review is to go through the molecular epidemiology of CRAB, in an endemic area and highlight its potential future evolution.

Entities:  

Keywords:  Acinetobacter baumannii; OXA-type carbapenemases; carbapenem resistance; molecular epidemiology

Mesh:

Substances:

Year:  2017        PMID: 28604100     DOI: 10.2217/fmb-2016-0200

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  10 in total

1.  Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit.

Authors:  Theodoros Karampatakis; Katerina Tsergouli; Lida Politi; Georgia Diamantopoulou; Elias Iosifidis; Charalampos Antachopoulos; Aggeliki Karyoti; Maria Sdougka; Athanassios Tsakris; Emmanuel Roilides
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

2.  Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii.

Authors:  Mirian Marcolan De Mello; Patrícia Pimentel De Barros; Renata de Cassia Bernardes; Silvio Rubens Alves; Naiara Pires Ramanzini; Lívia Mara Alves Figueiredo-Godoi; Ana Carolina Chipoletti Prado; Antonio Olavo Cardoso Jorge; Juliana Campos Junqueira
Journal:  Lasers Med Sci       Date:  2019-03-20       Impact factor: 3.161

3.  Decoding Acinetobacter baumannii biofilm dynamics and associated protein markers: proteomic and bioinformatics approach.

Authors:  Monika Choudhary; Shubham Kaushik; Arti Kapil; Rahul Shrivastava; Jitendraa Vashistt
Journal:  Arch Microbiol       Date:  2022-03-03       Impact factor: 2.552

4.  Occurrence and Characteristics of ESBL- and Carbapenemase- Producing Escherichia coli from Wild and Feral Birds in Greece.

Authors:  Zoi Athanasakopoulou; Celia Diezel; Sascha D Braun; Marina Sofia; Alexios Giannakopoulos; Stefan Monecke; Dominik Gary; Domenique Krähmer; Dimitris C Chatzopoulos; Antonia Touloudi; Periklis Birtsas; Matina Palli; Giorgos Georgakopoulos; Vassiliki Spyrou; Efthymia Petinaki; Ralf Ehricht; Charalambos Billinis
Journal:  Microorganisms       Date:  2022-06-14

5.  Development and Clinical Application of a Recombinase Polymerase Amplification-Lateral Flow Strip Assay for Detection of Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Lei Wang; Dunpo Sun; Li Chen; Ping Zhou; Kun Wang; Fang Wang; Xingqi Lei; Yan Wang; Yingzhi Lu; Guanhong Huang; Xuzhu Gao
Journal:  Front Cell Infect Microbiol       Date:  2022-05-11       Impact factor: 6.073

6.  Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant Acinetobacter baumannii in ICU Rooms.

Authors:  Xiufeng Zhang; Fangping Li; Furqan Awan; Hongye Jiang; Zhenling Zeng; Weibiao Lv
Journal:  Front Cell Infect Microbiol       Date:  2021-02-26       Impact factor: 5.293

Review 7.  Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.

Authors:  Stamatis Karakonstantis; Evangelos I Kritsotakis; Achilleas Gikas
Journal:  Infection       Date:  2020-09-01       Impact factor: 3.553

8.  Major Bloodstream Infection-Causing Bacterial Pathogens and Their Antimicrobial Resistance in South Korea, 2017-2019: Phase I Report From Kor-GLASS.

Authors:  Dokyun Kim; Eun-Jeong Yoon; Jun Sung Hong; Min Hyuk Choi; Hyun Soo Kim; Young Ree Kim; Young Ah Kim; Young Uh; Kyeong Seob Shin; Jeong Hwan Shin; Jeong Su Park; Kyoung Un Park; Eun Jeong Won; Soo Hyun Kim; Jong Hee Shin; Jung Wook Kim; SungYoung Lee; Seok Hoon Jeong
Journal:  Front Microbiol       Date:  2022-01-06       Impact factor: 5.640

9.  Plethora of Resistance Genes in Carbapenem-Resistant Gram-Negative Bacteria in Greece: No End to a Continuous Genetic Evolution.

Authors:  Katerina Tsilipounidaki; Zoi Athanasakopoulou; Elke Müller; Sindy Burgold-Voigt; Zoi Florou; Sascha D Braun; Stefan Monecke; Nikolaos K Gatselis; Kalliopi Zachou; Aggelos Stefos; Ilias Tsagalas; Marina Sofia; Vassiliki Spyrou; Charalambos Billinis; George N Dalekos; Ralf Ehricht; Efthymia Petinaki
Journal:  Microorganisms       Date:  2022-01-13

10.  Differential Gene Expression of Efflux Pumps and Porins in Clinical Isolates of MDR Acinetobacter baumannii.

Authors:  Khalid I AlQumaizi; Sunil Kumar; Razique Anwer; Shoeb Mustafa
Journal:  Life (Basel)       Date:  2022-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.